LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
 32.28 770.25 3129 3392 0.9222 0.9257
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 34.50 770.25 3339 3712 0.8995 0.9088
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 34.50 770.25 3360 3712 0.9052 0.9141
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 770.25 3625 4086 0.8872 0.9030
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 770.25 3633 4086 0.8891 0.9047
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 38.95 770.25 3958 4543 0.8711 0.8950
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 38.95 770.25 3926 4543 0.8640 0.8890
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 41.17 770.25 4367 5010 0.8716 0.9008
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 41.17 770.25 4303 5010 0.8588 0.8904
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 43.39 770.25 4733 5404 0.8758 0.9078
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 43.39 770.25 4584 5404 0.8482 0.8862
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 45.61 770.25 4954 5813 0.8522 0.8933
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 45.61 770.25 4869 5813 0.8376 0.8821
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 47.83 770.25 5258 6223 0.8449 0.8912
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 47.83 770.25 5180 6223 0.8323 0.8819
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 50.05 770.25 5490 6629 0.8281 0.8822
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 50.05 770.25 5370 6629 0.8100 0.8688
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 52.27 770.25 5914 7058 0.8378 0.8923
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 52.27 770.25 5779 7058 0.8187 0.8787
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 54.49 770.25 6380 7555 0.8444 0.8999
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 54.49 770.25 6064 7555 0.8026 0.8709
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 56.71 770.25 6703 8001 0.8377 0.8978
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 56.71 770.25 6388 8001 0.7983 0.8710
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 58.94 770.25 6893 8444 0.8163 0.8859
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 58.94 770.25 6728 8444 0.7967 0.8727
MN20160304_L02
N21